Inside informationEnglish
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 28/05/2026, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 114354_20260528